DK1443940T3 - Farmaceutisk præparat på basis af mikroniseret progesteron, fremstillingsfremgangsmåde og anvendelser deraf - Google Patents

Farmaceutisk præparat på basis af mikroniseret progesteron, fremstillingsfremgangsmåde og anvendelser deraf

Info

Publication number
DK1443940T3
DK1443940T3 DK02788051T DK02788051T DK1443940T3 DK 1443940 T3 DK1443940 T3 DK 1443940T3 DK 02788051 T DK02788051 T DK 02788051T DK 02788051 T DK02788051 T DK 02788051T DK 1443940 T3 DK1443940 T3 DK 1443940T3
Authority
DK
Denmark
Prior art keywords
oil
preparation
micronized progesterone
progesterone
pharmaceutical preparation
Prior art date
Application number
DK02788051T
Other languages
Danish (da)
English (en)
Inventor
Antoine Besins
Jerome Besse
Original Assignee
Besins Int Belgique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Int Belgique filed Critical Besins Int Belgique
Application granted granted Critical
Publication of DK1443940T3 publication Critical patent/DK1443940T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
DK02788051T 2001-11-13 2002-11-13 Farmaceutisk præparat på basis af mikroniseret progesteron, fremstillingsfremgangsmåde og anvendelser deraf DK1443940T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0114653A FR2832065B1 (fr) 2001-11-13 2001-11-13 Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations
PCT/FR2002/003879 WO2003041720A1 (fr) 2001-11-13 2002-11-13 Composition pharmaceutique a base de progesterone micronisee, son procede de preparation et ses utilisations

Publications (1)

Publication Number Publication Date
DK1443940T3 true DK1443940T3 (da) 2007-01-29

Family

ID=8869332

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02788051T DK1443940T3 (da) 2001-11-13 2002-11-13 Farmaceutisk præparat på basis af mikroniseret progesteron, fremstillingsfremgangsmåde og anvendelser deraf

Country Status (25)

Country Link
US (5) US20030092691A1 (es)
EP (1) EP1443940B1 (es)
KR (1) KR100911790B1 (es)
CN (1) CN1263453C (es)
AT (1) ATE339958T1 (es)
AU (1) AU2002352334B2 (es)
BR (1) BRPI0214043B8 (es)
CY (1) CY1106293T1 (es)
DE (1) DE60214876T2 (es)
DK (1) DK1443940T3 (es)
EA (1) EA006550B1 (es)
ES (1) ES2272793T3 (es)
FR (1) FR2832065B1 (es)
HK (1) HK1064606A1 (es)
HU (1) HU229341B1 (es)
IL (2) IL161668A0 (es)
MA (1) MA27081A1 (es)
NO (1) NO335044B1 (es)
NZ (1) NZ532659A (es)
OA (1) OA12726A (es)
PL (1) PL206096B1 (es)
PT (1) PT1443940E (es)
UA (1) UA77451C2 (es)
WO (1) WO2003041720A1 (es)
ZA (1) ZA200403288B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2832065B1 (fr) 2001-11-13 2004-11-05 Besins Int Belgique Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations
CA2533013C (en) * 2003-07-17 2011-07-26 Banner Pharmacaps, Inc. Controlled release preparations
AU2006249349B2 (en) * 2005-05-26 2012-01-12 Teva Women's Health, Inc. Oral dosage forms comprising progesterone and methods of making and using the same
US8828981B2 (en) * 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
EP2055306A1 (de) * 2007-11-05 2009-05-06 Bayer Schering Pharma AG Verwendung eines Gestagens in Kombination mit einem Estrogen und einem oder mehreren pharmazeutisch annehmbaren hilfsstoffen/Trägern zur laktosefreien oralen Kontrazeption
FR2947178B1 (fr) 2009-06-29 2012-07-06 Effik Composition pharmaceutique a base de progesterone micronisee et ses utilisations
CN102091054B (zh) * 2009-12-14 2014-04-16 浙江爱生药业有限公司 黄体酮制剂组合物及其制备方法
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
JP6290081B2 (ja) * 2011-09-15 2018-03-07 フリウルケム、ソシエタ、ペル、アチオニＦｒｉｕｌｃｈｅｍ Ｓｐａ 動物への経口投与用組成物、その製造方法およびその使用
WO2013049749A2 (en) 2011-09-29 2013-04-04 Plx Pharma Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2016018993A1 (en) 2014-07-29 2016-02-04 Therapeuticsmd, Inc. Transdermal cream
MX2017016823A (es) 2015-06-22 2018-03-12 Lipocine Inc Composiciones orales que contienen éster de 17- hydroxiprogesterona y métodos relacionados.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
EP3395332A1 (en) * 2017-04-28 2018-10-31 Chemo Research, S.L. Hormone softgel capsules and a process for the preparation thereof
US10285998B1 (en) 2018-04-04 2019-05-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
WO2021195319A1 (en) 2020-03-26 2021-09-30 Plx Opco Inc. PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND- METHODS FOR MAKING AND USING SAME

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
JPS60258110A (ja) * 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液
US5140021A (en) * 1986-04-16 1992-08-18 Genesis Systems Corporation Method and dosage form for treatment of premenstrual syndrome
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
IT1256386B (it) * 1992-11-13 1995-12-04 Luigi Boltri Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo
ATE150640T1 (de) * 1993-12-22 1997-04-15 Oreal Kosmetisches oder dermatologisches pulver, verfahren zu seiner herstellung und verwendungen
FR2747042B1 (fr) * 1996-04-05 1998-06-05 Besins Iscovesco Lab Medicament a base de progesterone et d'oestradiol
GB9608719D0 (en) * 1996-04-26 1996-07-03 Scherer Ltd R P Pharmaceutical compositions
ES2152671T3 (es) * 1996-05-01 2001-02-01 Us Gov Health & Human Serv Derivados de progesterona sustituidos en posicion 21 como nuevos agentes antiprogestacionales.
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone
FR2832065B1 (fr) 2001-11-13 2004-11-05 Besins Int Belgique Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations

Also Published As

Publication number Publication date
ES2272793T3 (es) 2007-05-01
EA006550B1 (ru) 2006-02-24
NZ532659A (en) 2006-04-28
US20050004076A1 (en) 2005-01-06
HUP0401935A3 (en) 2011-02-28
IL161668A0 (en) 2004-09-27
US20110135719A1 (en) 2011-06-09
UA77451C2 (en) 2006-12-15
EP1443940A1 (fr) 2004-08-11
EP1443940B1 (fr) 2006-09-20
US20090123534A1 (en) 2009-05-14
KR20050058231A (ko) 2005-06-16
IL161668A (en) 2009-09-01
HU229341B1 (en) 2013-11-28
PL206096B1 (pl) 2010-06-30
DE60214876D1 (de) 2006-11-02
CN1585644A (zh) 2005-02-23
FR2832065A1 (fr) 2003-05-16
CN1263453C (zh) 2006-07-12
PL369131A1 (en) 2005-04-18
CY1106293T1 (el) 2011-10-12
HUP0401935A2 (hu) 2005-01-28
US20030092691A1 (en) 2003-05-15
FR2832065B1 (fr) 2004-11-05
NO20042002L (no) 2004-05-14
KR100911790B1 (ko) 2009-08-12
US8435561B2 (en) 2013-05-07
AU2002352334B2 (en) 2008-10-23
BR0214043A (pt) 2004-10-13
EA200400668A1 (ru) 2004-10-28
ZA200403288B (en) 2005-07-27
HK1064606A1 (es) 2005-02-04
MA27081A1 (fr) 2004-12-20
ATE339958T1 (de) 2006-10-15
US7431941B2 (en) 2008-10-07
OA12726A (en) 2006-06-27
NO335044B1 (no) 2014-09-01
PT1443940E (pt) 2007-01-31
DE60214876T2 (de) 2007-04-05
BRPI0214043B1 (pt) 2019-12-31
US20120276194A1 (en) 2012-11-01
WO2003041720A1 (fr) 2003-05-22
US7829115B2 (en) 2010-11-09
BRPI0214043B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
DK1443940T3 (da) Farmaceutisk præparat på basis af mikroniseret progesteron, fremstillingsfremgangsmåde og anvendelser deraf
WO2005055932A3 (en) Therapeutic combinations and methods including irm compounds
DE60331236D1 (de) Orale zusammensetzungen zur behandlung von diabetes
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
ATE540678T1 (de) Prodrugs aus gaba-analoga, zusammensetzungen und ihre verwendungen
HK1149764A1 (es)
UY26130A1 (es) Compuestos para tratar la obesidad
MXPA05013075A (es) Inhibidores de p-38 basados en heterociclo de 5 miembros.
UY27165A1 (es) 6,7,8,9-tetrahidro-5h-benzocicolheptenil aminas aciladas y su uso como farmacos
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
ATE381246T1 (de) Elektronische schaltung und verfahren zum betrieb einer hochdrucklampe
WO2001001974A3 (en) Naaladase inhibitors in anxiety and memory disorders
AU2002238116A1 (en) Multiple hot zone igniters
ATE532198T1 (de) Hochspannungs-abschaltungsschutzschalter und betriebsverfahren dafür
EP1558282A4 (en) ANTICANCER COMPOSITIONS AND AGAINST INFECTIOUS DISEASES, AND METHODS OF USE THEREOF
GB0209998D0 (en) Use
DE69905939D1 (de) Enterales pharmazeutisches präparat
WO2004058799A3 (en) Methods and compositions for inhibiting binding of ige to a high affinity receptor
WO2003052823A3 (en) On-chip impedance matching circuit using bond wire inductors
TW200500585A (en) Device and method for heat treatment
MXPA04006047A (es) Composicion farmaceutica para prevencion y tratamiento de eyaculacion precoz y/o hipersensibilidad durante la estimulacion sexual.
ATE235249T1 (de) Die von morphogenen peptiden hervorgerufene wiederherstellung von gewebe aus sinneszellen
LT2002037A (en) Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
WO2004103291A3 (en) Extended release compositions of proton pump inhibitor
ATE543510T1 (de) Bowman-birk-hemmer-zusammensetzungen zur behandlung von muskelatrophie und degenerativer muskelerkrankung